Literature DB >> 28444149

First 2 Extensively Drug-Resistant Tuberculosis Cases From Myanmar Treated With Bedaquiline.

Htin Lin Aung1, Wint Wint Nyunt2, Yang Fong3, Gregory M Cook1,1, Si Thu Aung4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28444149     DOI： 10.1093/cid/cix365

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.

Authors:  Suha Kadura; Nicholas King; Maria Nakhoul; Hongya Zhu; Grant Theron; Claudio U Köser; Maha Farhat
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

2.  Acquired Resistance to Antituberculosis Drugs.

Authors:  Htin Lin Aung; Wint Wint Nyunt; Yang Fong; Bruce Russell; Gregory M Cook; Si Thu Aung
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

3.  Targeting the Serine Pathway: A Promising Approach against Tuberculosis?

Authors:  Marie Haufroid; Johan Wouters
Journal:  Pharmaceuticals (Basel)       Date:  2019-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.